Fed. Circ. Weighs In On Obviousness-Type Double Patenting
In a recent split decision in UCB v. Accord, the Federal Circuit affirmed a finding that claims covering a pharmaceutical compound were not invalid for obviousness-type double patenting, or OTDP.[1] The...To view the full article, register now.
Already a subscriber? Click here to view full article